Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-8.70T.
ENTERPRISE VALUE (EV)
$-8.70T
BioVie Inc.
Market Cap
$11.09M
Enterprise Value (EV)
$-8.70T
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| BioVie Inc. (BIVI) | $11.09M | $-8.70T |
| Cerenome, Inc. (CNSY)vs › | $11.10M | $8.77M |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | $10.23M |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | $4.56M |
| Biofrontera Inc. (BFRI)vs › | $11.38M | $14.22M |
| Caring Brands, Inc. (CABR)vs › | $10.68M | $8.86M |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.50M | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | $211476.00 |
| Pluri Inc. (PLUR)vs › | $11.54M | $42.93M |
| Polyrizon Ltd. (PLRZ)vs › | $10.47M | $2.06M |
Market Cap
$11.09M
Total Debt
$275.43B
Cash
$8.98T
Enterprise Value
$-8.70T
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
